Skip to main content
Journal cover image

Utilization of second-line immuno-oncology agents and associated health outcomes among united states veterans with advanced non-small cell lung cancer

Publication ,  Conference
Allo, M; Gu, L; Vashistha, V; Press, A; Kelley, M; Williams, C
Published in: JOURNAL FOR IMMUNOTHERAPY OF CANCER
November 6, 2019

Duke Scholars

Published In

JOURNAL FOR IMMUNOTHERAPY OF CANCER

ISSN

2051-1426

Publication Date

November 6, 2019

Volume

7

Publisher

BMC

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Allo, M., Gu, L., Vashistha, V., Press, A., Kelley, M., & Williams, C. (2019). Utilization of second-line immuno-oncology agents and associated health outcomes among united states veterans with advanced non-small cell lung cancer. In JOURNAL FOR IMMUNOTHERAPY OF CANCER (Vol. 7). BMC.
Allo, Mina, Lin Gu, Vishal Vashistha, Ashlyn Press, Michael Kelley, and Christina Williams. “Utilization of second-line immuno-oncology agents and associated health outcomes among united states veterans with advanced non-small cell lung cancer.” In JOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol. 7. BMC, 2019.
Allo M, Gu L, Vashistha V, Press A, Kelley M, Williams C. Utilization of second-line immuno-oncology agents and associated health outcomes among united states veterans with advanced non-small cell lung cancer. In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2019.
Allo M, Gu L, Vashistha V, Press A, Kelley M, Williams C. Utilization of second-line immuno-oncology agents and associated health outcomes among united states veterans with advanced non-small cell lung cancer. JOURNAL FOR IMMUNOTHERAPY OF CANCER. BMC; 2019.
Journal cover image

Published In

JOURNAL FOR IMMUNOTHERAPY OF CANCER

ISSN

2051-1426

Publication Date

November 6, 2019

Volume

7

Publisher

BMC

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3204 Immunology